178 related articles for article (PubMed ID: 3172137)
21. In vitro antifungal activity and structure-activity relationship studies of novel cis-5-acyloxyalkyl-3-phenyl-3-(1H-imidazol-1-ylmethyl)-2- methylisoxazolidine derivatives.
Maryniak DM; Mullen GB; Allen SD; Mitchell JT; Kinsolving CR; St Georgiev V
Ann N Y Acad Sci; 1988; 544():378-80. PubMed ID: 3214081
[No Abstract] [Full Text] [Related]
22. Studies on antifungal agents. 17. Effects of the C-5-substitution on the in vitro activity of novel 3,5-substituted isoxazolidines.
Dormer PA; Mullen GB; Mitchell JT; Allen SD; St Georgiev V
Chemotherapy; 1988; 34(5):411-4. PubMed ID: 3053064
[TBL] [Abstract][Full Text] [Related]
23. Antifungal agents. 10. Synthesis and antifungal activities of aryl-(1H-imidazol-1-yl)-(isoquinolin-1-yl) methane derivatives.
Silvestri R; Pagnozzi E; Troccoli F; Stefancich G; Massa S; Apuzzo G; Perazzi ME; Artico M; Simonetti G
Farmaco; 1995 Apr; 50(4):227-38. PubMed ID: 7669167
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and microbial inhibition study of novel 5-imidazolyl substituted isoxazolidines.
Sadashiva MP; Mallesha H; Hitesh NA; Rangappa KS
Bioorg Med Chem; 2004 Dec; 12(24):6389-95. PubMed ID: 15556757
[TBL] [Abstract][Full Text] [Related]
25. In vitro activity of novel 5-carbonyl derivatives of 3-phenyl-3-(1H-imidazol-1-ylmethyl)- 2-methyl-isoxazolidines.
Bennett GA; Mullen GB; DeCory TR; Allen SD; Mitchell JT; St Georgiev V
Ann N Y Acad Sci; 1988; 544():396-9. PubMed ID: 3214085
[No Abstract] [Full Text] [Related]
26. Studies on antifungal agents. 20. Effect of the nitrogen substitution on the in vitro activity of novel 3,5-substituted isoxazolidines.
Swift PA; Mullen GB; Mitchell JT; Allen SD; St Georgiev V
Chemotherapy; 1989; 35(2):130-2. PubMed ID: 2667902
[TBL] [Abstract][Full Text] [Related]
27. Antifungal agents. III. Naphthyl and thienyl derivatives of 1H-imidazol-1-yl-4-phenyl-1H-pyrrol-3-ylmethane.
Massa S; Di Santo R; Costi R; Simonetti G; Retico A; Apuzzo G; Artico M
Farmaco; 1993 Jun; 48(6):725-36. PubMed ID: 8373500
[TBL] [Abstract][Full Text] [Related]
28. Optically active antifungal azoles. VIII. Synthesis and antifungal activity of 1-[(1R,2R)-2-(2,4-difluoro- and 2-fluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl]- 3-(4-substituted phenyl)-2(1H,3H)-imidazolones and 2-imidazolidinones.
Kitazaki T; Tasaka A; Tamura N; Matsushita Y; Hosono H; Hayashi R; Okonogi K; Itoh K
Chem Pharm Bull (Tokyo); 1999 Mar; 47(3):351-9. PubMed ID: 10212385
[TBL] [Abstract][Full Text] [Related]
29. Novel 5-phenyl(or phenoxyalkyl)-3-(2-furanyl)-3-(1H-imidazol-1-ylmethyl)-2- methylisoxazolidines. In vitro antifungal activity.
Bennett GA; Mullen GB; Mitchell JT; Allen SD; Kinsolving CR; St Georgiev V
Ann N Y Acad Sci; 1988; 544():384-6. PubMed ID: 3214083
[No Abstract] [Full Text] [Related]
30. Selection of orally active antifungal agents from 3,5-substituted isoxazolidine derivatives based on acute efficacy-safety profiles.
Palmer GC; Ordy MJ; Simmons RD; Strand JC; Radov LA; Mullen GB; Kinsolving CR; St Georgiev V; Mitchell JT; Allen SD
Antimicrob Agents Chemother; 1989 Jun; 33(6):895-905. PubMed ID: 2764540
[TBL] [Abstract][Full Text] [Related]
31. Antifungal agents. VI. In vitro antifungal activities of halobenzoyl esters of cis- and trans-[2-(1,1'-biphenyl-4-yl)-2-(1H-imidazol-1-ylmethyl)-1,3- dioxolan-4-yl]carbinols.
Stefancich G; Silvestri R; Pagnozzi E; Artico M; Retico A; Apuzzo G; Simonetti N
Farmaco; 1993 Aug; 48(8):1103-12. PubMed ID: 8216672
[TBL] [Abstract][Full Text] [Related]
32. cis-5-alkoxyalkyl-3-phenyl-3-(1H-imidazol-1-ylmethyl)-2- methylisoxazolidine derivatives.
Maryniak DM; Mullen GB; Mitchell JT; Allen SD; Kinsolving CR; St Georgiev V
Ann N Y Acad Sci; 1988; 544():373-4. PubMed ID: 3214079
[No Abstract] [Full Text] [Related]
33. In vitro activity of novel 5-(phenyl or phenoxyalkyl)-3-(2-thienyl)-3-(1H-imidazol-1-ylmethyl)-2- methylisoxazolidines.
Mullen GB; Mitchell JT; Allen SD; St Georgiev V
Ann N Y Acad Sci; 1988; 544():392-5. PubMed ID: 3214084
[No Abstract] [Full Text] [Related]
34. Antibacterial and antifungal agents. XV. Synthesis and antifungal activity of structural analogues of bifonazole and ketoconazole.
Stefancich G; Artico M; Ortar G; Silvestri R; Simonetti G; Apuzzo G; Artico M
Arch Pharm (Weinheim); 1992 Nov; 325(11):687-94. PubMed ID: 1485835
[TBL] [Abstract][Full Text] [Related]
35. In vitro antifungal activity of novel substituted 3,5-diphenyl-3-(1H-1,2,4-triazol-1-ylmethyl)-2- methylisoxazolidine derivatives.
Bennett GA; Swift PA; Mullen GB; Mitchell JT; Allen SD; Kinsolving CR; St Georgiev V
Ann N Y Acad Sci; 1988; 544():375-7. PubMed ID: 3214080
[No Abstract] [Full Text] [Related]
36. Synthesis and antimyoctic properties of 1-(2-alkyl-2-phenylethyl)-1H-imidazoles.
Heeres J; Backx LJ; Van Cutsem JM
J Med Chem; 1976 Sep; 19(9):1148-55. PubMed ID: 978678
[TBL] [Abstract][Full Text] [Related]
37. [Synthesis and antifungal activity of 1-(2-[(4-substituted-phenyl) methoxy]-2-(substituted-phenyl) ethyl)-1H-azoles].
Wu QY; Li K; Liu CM; Liu GX; Wang XY
Yao Xue Xue Bao; 1993; 28(9):661-7. PubMed ID: 8010011
[TBL] [Abstract][Full Text] [Related]
38. Synthesis of new isoxazoles and dihydroisoxazoles and in vitro evaluation of their antifungal activity.
Chevreuil F; Landreau A; Séraphin D; Larcher G; Mallet S; Bouchara JP; Richomme P
J Enzyme Inhib Med Chem; 2007 Oct; 22(5):563-9. PubMed ID: 18035824
[TBL] [Abstract][Full Text] [Related]
39. [Synthesis and antifungal activity of 1-(1H-1,2,4-triazole-1-yl)-2-(2,4-difluorophenyl)-3-substituted-2-propanols].
Zhang DZ; Zhou TS; Wu YJ; Liu CM; Ma MC; Feng XT
Yao Xue Xue Bao; 1997 Dec; 32(12):943-9. PubMed ID: 11596195
[TBL] [Abstract][Full Text] [Related]
40. cis-5-alkyl(or alkenyl)-3-phenyl-3-(1H-imidazole-1-ylmethyl)-2- methylisoxazolidine derivatives. In vitro antifungal activity and structure-activity relationships.
Swift PA; Bennett GA; Mullen GB; Mitchell JT; Allen SD; Kinsolving CR; St Georgiev V
Ann N Y Acad Sci; 1988; 544():381-3. PubMed ID: 3214082
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
